Add to ORKGjpet.aspetjournals.org D ow nloaded from JPET #159145 2 Running title page Running title: Cannabidiol as an anti-epileptic agent Corresponding author
jpet.aspetjournals.org D ow nloaded from JPET #205245 2 Running title: Using an opioid agonist/NK1 a...
This article has not been copye ited and formatted. The final version may differ from this version
Epilepsy is one of the most common chronic disorders of the brain affecting around 70 million people...
jpet.aspetjournals.org D ow nloaded from JPET #69146 2 Running Title: Brain injury-induced non-convu...
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted, cannabino...
The use of Cannabis for medicinal purposes has been documented since ancient times, where one of its...
grant on behalf of all authors, an exclusive licence (or non-exclusive for government employees) on ...
The FDA recently approved the first cannabidiol oral medication to treat refractory epilepsy in pati...
Abstract: in childhood, epilepsy is the most common globally widespread neurological problem, usuall...
ay 9, 2016 jpet.aspetjournals.org D ow nloaded from 2 JPET # 192799 a) Running title: 3,5-dihydroxy...
Cannabidiol (CBD) is the main non-psychotropic component of the glandular hairs of Cannabis saliva. ...
Cannabidiol (CBD) is the main non-psychotropic component of the glandular hairs of Cannabis saliva. ...
Cannabidiol (CBD) is the main non-psychotropic component of the glandular hairs of Cannabis saliva. ...
jpet.aspetjournals.org D ow nloaded from JPET #193284 2 Running title page: Running Title: In vitro ...
The therapeutic potential of cannabidiol (CBD) in seizure disorders has been known for many years, b...
jpet.aspetjournals.org D ow nloaded from JPET #205245 2 Running title: Using an opioid agonist/NK1 a...
This article has not been copye ited and formatted. The final version may differ from this version
Epilepsy is one of the most common chronic disorders of the brain affecting around 70 million people...
jpet.aspetjournals.org D ow nloaded from JPET #69146 2 Running Title: Brain injury-induced non-convu...
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted, cannabino...
The use of Cannabis for medicinal purposes has been documented since ancient times, where one of its...
grant on behalf of all authors, an exclusive licence (or non-exclusive for government employees) on ...
The FDA recently approved the first cannabidiol oral medication to treat refractory epilepsy in pati...
Abstract: in childhood, epilepsy is the most common globally widespread neurological problem, usuall...
ay 9, 2016 jpet.aspetjournals.org D ow nloaded from 2 JPET # 192799 a) Running title: 3,5-dihydroxy...
Cannabidiol (CBD) is the main non-psychotropic component of the glandular hairs of Cannabis saliva. ...
Cannabidiol (CBD) is the main non-psychotropic component of the glandular hairs of Cannabis saliva. ...
Cannabidiol (CBD) is the main non-psychotropic component of the glandular hairs of Cannabis saliva. ...
jpet.aspetjournals.org D ow nloaded from JPET #193284 2 Running title page: Running Title: In vitro ...
The therapeutic potential of cannabidiol (CBD) in seizure disorders has been known for many years, b...
jpet.aspetjournals.org D ow nloaded from JPET #205245 2 Running title: Using an opioid agonist/NK1 a...
This article has not been copye ited and formatted. The final version may differ from this version
Epilepsy is one of the most common chronic disorders of the brain affecting around 70 million people...